|
- 积分
- 1334
- 威望
- 1334
- 包包
- 4744
|
实在想做，可以看这里% `1 \! c7 c& E# Q' T4 ~1 }
http://clinicaltrials.gov/ct2/re ... +cord+AND+stem+cell! `5 s% p% v+ w0 k
Found 57 studies with search of: spinal cord AND stem cell + ~; l; g; e S Y& S
Hide studies that are not seeking new volunteers.
- |4 P& z& X: r' Q8 a# IHide studies with unknown recruitment status. Display Options Rank Status Study % K! i E& Z) ^1 D- m$ F
1 Recruiting Autologous Bone Marrow Stem Cell Transplantation in Patients With Spinal Cord Injury Condition: Spinal Cord Injury " {) E; i1 g) O/ U
Intervention: Procedure: Stem Cell Transplantation , B0 G- W2 I |) E9 E2 v# b
2 ^4 R1 ?9 Y) R( u) P
2 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis
8 r' h. \- [# V0 YIntervention: Procedure: surgical implantation
$ _# t. A$ X4 c . g% N% g9 _; h8 L: E
3 Recruiting Autologous Stem Cells for Spinal Cord Injury (SCI) in Children Condition: Spinal Cord Injury
2 q, O* c, j; F9 e. o7 P* d: TIntervention: Biological: bone marrow progenitor cells (BMPC) autologous transplantation
+ i9 D3 {) `* J9 A* R* O( E6 _
: U% `5 _+ z& O. l4 Active, not recruiting Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury Condition: Spinal Cord Injury 1 ?+ m0 d, C; s1 j( [
Intervention: Biological: autologous mesenchymal stem cells 8 I( q- i# Z/ M l4 B
0 | f3 e) S( R4 s5 Recruiting Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Patients With Thoracic Spinal Cord Injury Conditions: Spinal Cord Injury Thoracic; Spinal Cord Injury
$ E" U6 @. c. g( _Intervention: Procedure: HuCNS-SC cells ) `/ d0 S* G, Y- `/ b8 v) ^
2 a/ ^) X h Y6 {2 n; k
6 Completed Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury Condition: Spinal Cord Injuries
/ Y) k5 l6 \5 T0 c5 }Interventions: Procedure: laminectomy; Procedure: Intrathecal 0 X0 g, S! K8 {* d' {+ d
% Y5 P3 L0 }: ]9 R5 C
7 Completed Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Neuroblastoma; Sarcoma
. j m8 ?+ @+ ^' _* q4 }! JInterventions: Biological: filgrastim; Drug: carboplatin; Drug: cisplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: thiotepa; Drug: vincristine sulfate; Procedure: conventional surgery; Procedure: peripheral blood stem cell transplantation & \( l3 E) ]) y9 F3 y7 w
% q: N9 _4 G- }- [( T
8 Completed Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. Condition: Spinal Cord Injury
1 H1 H( ?9 ^. Y$ N% dIntervention: Other: Autologous Adipose Derived Mesenchymal Stem Cells
( ^3 v7 z& J! F; n# F; ]6 c
7 M( {+ N: e; n) M+ ]" x2 j, a9 Recruiting Bone Graft Materials Observational Registry Conditions: Degenerative Disc Disease; Herniated Disc; Spinal Stenosis; Spondylolithesis; Spinal Deformity; Cervical Myelopathy; Failed Back Surgery Syndrome; Spinal Cord Neoplasms
# w: y/ {7 u) yIntervention: Device: Bone growth substitute, autograft or allograft ( ~, n0 ^( L% E
3 k3 Q. h, r3 z5 c _
10 Recruiting Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy Condition: Autoimmune Disorder ! C0 ^$ D; ?0 V1 |+ \5 a
Interventions: Biological: anti-thymocyte globulin; Drug: carmustine; Drug: cytarabine; Drug: etoposide; Drug: melphalan; Drug: prednisone; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: syngeneic bone marrow transplantation; Other: laboratory biomarker analysis ; \( w" R( K3 \" }
, y# E. C# I! O( i. T; g% K
11 Active, not recruiting Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Condition: Multiple Sclerosis
2 o+ u2 P6 Z; oIntervention: Procedure: hematopoietic stem cell transplantation
. l, v" k8 f) U' L! Z7 O 6 V( A$ J5 y ?0 W2 _( k8 {$ R
12 Recruiting Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optica Condition: Neuromyelitis Optica (NMO) 7 z4 { j' |7 `# i! D/ M* y
Intervention: Procedure: AHSCT 2 v# ~( v u; l% h" W+ |# y
9 R; s! S% H6 ?13 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study Condition: Multiple Sclerosis
: |8 q4 O8 ^& j. S uInterventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant
1 X/ k' w- W( n) v g# T/ c
) c# e6 o6 e( M& o14 Completed Cell Transplant in Spinal Cord Injury Patients Condition: Chronic Spinal Cord Injury 0 W" F, N, o* ?# c
Interventions: Procedure: Autologous bone marrow transplant; Procedure: Physical therapy $ ]2 ~9 E5 F& S/ D8 w- w/ I
# d9 \' o; \" o. o# A" S
15 Active, not recruiting Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus Condition: Lupus Erythematosus, Systemic . x- |, I4 P* m% j
Interventions: Drug: fludarabine phosphate; Drug: cyclophosphamide; Biological: Rituxan (rituximab); Biological: filgrastim; Drug: methylprednisolone; Other: immunologic technique; Other: laboratory biomarker analysis; Procedure: autologous hematopoietic stem cell transplantation , M2 w. e5 [2 P3 U. ]- A/ N: `
' R6 O6 S3 u2 I; E1 p+ N% N
16 Unknown † Mesenchymal Stem Cells for the Treatment of MS Condition: Multiple Sclerosis
! _/ J, O2 @$ D) fIntervention: Biological: injection of autologous stem cells ) o8 o% s. j: X# r; o
9 b, J) C: j- u" W4 `
17 Recruiting Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Condition: Lymphoma
1 [# ^: K: n' P2 g; ]6 ^Interventions: Drug: carmustine; Drug: cyclophosphamide; Drug: etoposide; Procedure: peripheral blood stem cell transplantation; Radiation: radiation therapy; Biological: G-CSF
" F7 _" M }1 n- K
) B0 I0 N. i$ a2 S1 m/ V7 [ [18 Recruiting Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Condition: Sarcoma
: X" U# B% F! k6 bInterventions: Biological: dactinomycin; Drug: busulfan; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: ifosfamide; Drug: melphalan; Drug: vincristine sulfate; Procedure: autologous hematopoietic stem cell transplantation; Procedure: conventional surgery; Radiation: radiation therapy 8 O T! e/ j* R; d0 P; h( ]5 W
2 z& K- Q7 t, `0 {& j4 [19 Recruiting Clinical Trial on The Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis (Extension CMN/ELA) Condition: Amyotrophic Lateral Sclerosis
0 U+ Z& J; e2 dInterventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Intrathecal infusion of autologous bone marrow stem cells; Procedure: Intrathecal infusion of placebo (saline solution).
/ g2 n [; q3 L/ |5 y% R) ?5 R 7 Q. ?4 |3 l- g
20 Active, not recruiting Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma Condition: Neuroblastoma 5 O8 a" D+ h4 b# U
Interventions: Drug: Cisplatin and Etoposide; Drug: Adriamycin and Cyclophosphamide , E) i3 V1 @' ~" @8 g
# S f' g; N* y4 V% JFound 57 studies with search of: spinal cord AND stem cell
! K! t; w: s9 R: A: h: s: ~Hide studies that are not seeking new volunteers.
' N9 z* w/ N. W- }* f. G" lHide studies with unknown recruitment status. Display Options Rank Status Study
4 v* U. ^4 ^% K! B+ `2 z21 Completed Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis % q1 D w8 m8 b2 g0 c( E/ q3 g
Interventions: Procedure: Laminectomy and bone marrow stem cells transplantation; Procedure: Autologous bone marrow cells collection
% J6 M0 R( w/ z9 ~/ E6 t: X7 K
! A2 a0 @: }$ T# ~$ {22 Active, not recruiting Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis
8 N+ X' H) X( M; R+ }* S$ M4 KIntervention: Biological: autologous mesenchymal stem cells
0 f( e6 o- T7 D$ s( T) T7 }# S
/ K. C8 g$ A8 F; @1 j* H( Q23 Active, not recruiting Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis Condition: Amyotrophic Lateral Sclerosis , n% e- b' k* t
Intervention: Biological: autologous bone marrow-derived stem cells . c- g" g1 V' v: w1 f4 Y. j5 ^
9 _. `0 r% `5 l3 R. L& `, `! I24 Unknown † Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis : J& K1 ~2 I; j' `% o
Intervention: Drug: Cistanche Total Glycosides
7 o# z% B. l1 i, ] 5 Q! y& [7 ~4 i* b3 p$ ^( I$ e0 R
25 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response Condition: Amyotrophic Lateral Sclerosis 2 H1 G$ E H+ o, u1 d5 _* m: n2 d
Interventions: Drug: Granulocyte Colony Stimulating Factor; Drug: NS 7 [- {7 t! E$ A' j8 K: x/ |8 o W% }: j
+ q9 y( V+ c1 r5 U/ h
26 Active, not recruiting Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells Condition: Amyotrophic Lateral Sclerosis * ]2 U7 ?7 u! y8 D% y* t
Intervention: ; Q( N- q' l6 r8 P) |* i K$ N
; c7 X* O; F* L' }27 Not yet recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. Condition: Amyotrophic Lateral Sclerosis
& `8 x& l; f/ R/ r1 z, YInterventions: Biological: MSC-NTF cells transplantation (i.m.); Biological: MSC-NTF cells transplantation (i.t.)
7 K) o. W" W5 p* U$ `' o! } 2 S i- G8 n' h: E8 Z6 V
28 Active, not recruiting Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS) Condition: Amyotrophic Lateral Sclerosis $ K' _! V6 @# I6 A6 [( c* {8 `. O9 ]
Intervention: Drug: SB-509
/ v+ _# M4 \! ` 5 n5 i$ T" Y. u7 k/ B w
29 Active, not recruiting Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Extra-adrenal Paraganglioma
' Z _- f; X) J2 nInterventions: Drug: temozolomide; Drug: vorinostat; Genetic: DNA methylation analysis; Genetic: western blotting; Other: laboratory biomarker analysis; Other: pharmacological study
5 ?+ F+ ^! Q( m( P" Q7 t * L7 Z9 m r: o G0 M2 a
30 Active, not recruiting Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors Conditions: Brain and Central Nervous System Tumors; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific , Q; F$ `( N4 U2 K' ^- ^9 P
Interventions: Drug: carboplatin; Drug: tamoxifen citrate; Drug: topotecan hydrochloride; Other: pharmacological study ( V% M' W( G; v! S! }
. U8 \& a8 U' d7 b7 I3 w31 Recruiting Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia Condition: Critical Limb Ischemia
/ Y1 {$ |* V, d7 ^' X. A1 S2 S3 `Intervention: Biological: Cord blood stem cell injection
! V u1 r3 S* w! Z. v- c7 g
) E+ L* `7 H% ~6 R6 B |
|
发表于 2011-5-21 11:11
。。。。可否提供中文的信息，谢谢。
我看看先，看看有没有可行性的方案。